icon-folder.gif   Conference Reports for NATAP  
  38th Annual Meeting of the European Association for the Study of the Liver
Istanbul, Turkey. March 28-April 1, 2003
Back grey_arrow_rt.gif
  S. Gianni*, 1, 2 F.V. Mirante, 2 R. Fassati, 2 D. Forti, 2 V. Mazzaferro, 2 U. Cillo, 1, 2 A. Maffei Faccioli, 2 G.L. Grazi, 2 M. Salizzoni, 2 F. Filipponi, 2 M. Castagneto, 2 G. Tisone, 2 U. Valente, 2 F. Farinati, 1, 2 M. Pompili, 2 G. Gasbarrini, 2 R. Naccarato, 1, 2 S. Fagiuoli, 1, 2 *Presenting Author 1Department Of Surgical And Gastroentrological Sciences, Padua, Italy 2Monotematica 2000 AISF OLT Study Group, Padua, Italy
Background: HCC represents a frequent indication for OLT, however recurrence is common in advanced neoplasms. Aim: To evaluate potential predictive factors of HCC recurrence after OLT. Methods: We evaluated the role of hypothesized predictive factors of recurrence in a large series of transplants (587) in HCC, performed between '86 and '99 in Italy. Results: HCC recurrence occurred in 11.1% of the patients and represents the major cause of death (83, 7%). Mean time of HCC recurrence was 16, 7513, 9 (median 12 m.). Morpho-biological parameters that significantly related with recurrence were: tumor bilobarity (p=0, 006), number of nodules (>3; p<0, 0001), size of nodules (>5cm; p<0, 0001), absence of Milano's selection criteria (p=0, 0004), non-incidental diagnosis (p=0, 01), high levels of _FP (p=0, 02). Hystological parameters significantly related with recurrence were: microvascular invasion (p=0, 004), satellitosis (p<0, 0001). When all the above parameters were introduced in a multiple regression analysis, the following variables were selected as independent predictor of recurrence: size and number of nodules (p<0, 0001 and p=0, 05, respectively), incidental diagnosis (p=0, 013), satellitosis (p=0, 008), _FP levels (p=0, 008), microvascular invasion (p=0, 019) and thrombosis (p=0, 05). Pre-OLT neoadjuvant treatment significantly prolonged post-OLTdisease-free survival. Conclusions: HCC recurrence rate was 11, 1% at median time of 1 year after OLT, HCC being the main cause of death. The strongest predictive factors of post-transplant HCC recurrence are: size and number of nodules, non-incidental diagnosis, satellitosis, micro/macrovascular invasion and high AFP levels. These data suggest that the expansion of size criteria could negatively affect recurrence rates. Further investigations based on prospective studies are required.